CRX-100

N/A

Report date: 2024/02/05 16:46:35

Base Information

Drug NameCRX-100
Drug Alias NameCRX-100
ClassificationCell and gene therapy > Cell therapyBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsCytotoxic T lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesBioeclipse Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A